INDV
Indivior Pharmaceuticals, Inc.
Indivior Pharmaceuticals, Inc. (INDV) has 12 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 13, 2026.
Insiders have net sold $2.8M over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Joseph J. Ciaffoni
- Employees:1,030
- HQ:North Chesterfield, VA, US
- IPO:2014-12-29
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.8M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$5.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Scientific Officer | Sale | 18,586 | $765K | Jul 13 | SEC ↗ | |
Heidbreder ChristianFirst filing | Chief Scientific Officer | Sale | 18,586 | $707K | Jun 12 | SEC ↗ |
Preblick RyanFirst filing | Chief Financial Officer | Sale | 36,000 | $1.4M | Jun 10 | SEC ↗ |
Related companies
Indivior Pharmaceuticals, Inc. is in the Healthcare sector.